4//SEC Filing
Hackman Jeffrey S. 4
Accession 0001415889-25-010057
CIK 0001211583other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 6:12 PM ET
Size
9.1 KB
Accession
0001415889-25-010057
Insider Transaction Report
Form 4
Hackman Jeffrey S.
DirectorChief Executive Officer
Transactions
- Award
Restricted Share Unit
2025-03-28+75,000→ 75,000 totalExercise: $0.00From: 2026-03-28Exp: 2035-03-28→ Common Shares (75,000 underlying) - Award
Stock Options
2025-03-28+50,000→ 450,000 totalExercise: $6.50From: 2026-03-28Exp: 2035-03-28→ Common Shares (50,000 underlying)
Footnotes (4)
- [F1]On March 28, 2025, Jeffrey Hackman was awarded restricted share units to acquire 75,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan
- [F2]One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.
- [F3]On March 28, 2025, Jeffrey Hackman was granted incentive stock options to purchase 50,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
- [F4]One-third of the shares subject to this option may be exercised as of March 28, 2026 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028, 100% of the total number of shares subject to this option shall be vested
Documents
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
Related Parties
1- filerCIK 0001926254
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 6:12 PM ET
- Size
- 9.1 KB